Qualigen Therapeutics Appoints New Director and Officers Amid Changing Leadership Structure

Strategic Insights -

Qualigen Therapeutics, a Delaware-based biotechnology company, has made significant changes to its leadership structure with the appointment of Braeden Lichti as an independent member of the Board of Directors, effective October 8, 2024. Lichti is the founder and CEO of BWL Investments Ltd. and NorthStrive Companies, Inc., and has a background in investment and advisory services.

As part of this new appointment, Robert Lim has been appointed as the Chairperson of the Audit Committee, also effective October 8, 2024. This change comes as Mr. Matt Korenberg, independent member and chairman of the audit committee, tendered his resignation from all positions held with the Company on October 3, 2024, citing no disagreement with the Company's operations, policies, or practices.

Lichti brings a wealth of experience in the business and finance sectors, having established BWL Investments Ltd. in 2016 and NorthStrive Companies, Inc. in 2021. He also serves as the Chairman of Hydromer, Inc., a global leader in surface modification and coating solutions.

Key Takeaways:

  • Braeden Lichti, a seasoned investment and advisory expert, has been appointed as an independent member of the Board of Directors at Qualigen Therapeutics.
  • Lichti brings a wealth of experience to the table, having founded BWL Investments Ltd. in 2016 and NorthStrive Companies, Inc. in 2021.
  • Robert Lim has been appointed as the Chairperson of the Audit Committee, effective October 8, 2024.
  • Matt Korenberg, former chairman of the audit committee, tendered his resignation on October 3, 2024, citing no disagreement with the Company's operations, policies, or practices.
  • Lichti will serve on various committees of the Board to provide strategic guidance and expertise.
  • The Company's leadership structure has seen significant changes, with new appointments and resignations reflecting a shift in priorities.

Statistics:

  • October 8, 2024 - Braeden Lichti appointed as independent member of the Board of Directors.
  • October 8, 2024 - Robert Lim appointed as Chairperson of the Audit Committee.
  • October 3, 2024 - Matt Korenberg tendered his resignation from all positions held with the Company.
  • October 2024 - Qualigen Therapeutics restructures its leadership team with new appointments.
  • 2016 - Braeden Lichti establishes BWL Investments Ltd.
  • 2021 - Braeden Lichti founds NorthStrive Companies, Inc.
  • 1980 - Hydromer, Inc. was established.

Sources:

  • Qualigen Therapeutics, Inc. - Form 8-K filing (October 3, 2024).
  • Qualigen Therapeutics, Inc. - Board of Directors Agreement (October 8, 2024).
  • Qualigen Therapeutics, Inc. - Director Proprietary Information Agreement (October 8, 2024).
  • Qualigen Therapeutics, Inc. - Indemnification Agreement (October 8, 2024).
  • (c) 1995-2024 Cybernet Data Systems, Inc.